me naphos mb hyo 1

Generic: urinary antiseptic antispasmodic

Labeler: method pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG UNAPPROVED DRUG OTHER Inactive Finished

Drug Facts

Product Profile

Brand Name me naphos mb hyo 1
Generic Name urinary antiseptic antispasmodic
Labeler method pharmaceuticals
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hyoscyamine sulfate anhydrous .12 mg/1, methenamine 81.6 mg/1, methylene blue anhydrous 10.8 mg/1, sodium phosphate, monobasic, monohydrate 40.8 mg/1

Manufacturer
Method Pharmaceuticals

Identifiers & Regulatory

Product NDC 58657-454
Product ID 58657-454_41b576a1-2a59-9f3c-e063-6394a90aec7d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category UNAPPROVED DRUG OTHER
Listing Expiration 2026-12-31
Marketing Start 2015-12-01

Pharmacologic Class

Classes
oxidation-reduction activity [moa] oxidation-reduction agent [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 58657454
Hyphenated Format 58657-454

Supplemental Identifiers

RxCUI
1050325
UPC
0358657454012
UNII
OB570Z127K J50OIX95QV 8NAP7826UB 593YOG76RN

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name me naphos mb hyo 1 (source: ndc)
Generic Name urinary antiseptic antispasmodic (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .12 mg/1
  • 81.6 mg/1
  • 10.8 mg/1
  • 40.8 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (58657-454-01)
source: ndc

Packages (1)

Ingredients (4)

hyoscyamine sulfate anhydrous (.12 mg/1) methenamine (81.6 mg/1) methylene blue anhydrous (10.8 mg/1) sodium phosphate, monobasic, monohydrate (40.8 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "41b576a1-2a59-9f3c-e063-6394a90aec7d", "openfda": {"upc": ["0358657454012"], "unii": ["OB570Z127K", "J50OIX95QV", "8NAP7826UB", "593YOG76RN"], "rxcui": ["1050325"], "spl_set_id": ["2ae628e7-3b33-6a9a-e054-00144ff8d46c"], "manufacturer_name": ["Method Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (58657-454-01)", "package_ndc": "58657-454-01", "marketing_start_date": "20151201"}], "brand_name": "Me NaPhos MB Hyo 1", "product_id": "58657-454_41b576a1-2a59-9f3c-e063-6394a90aec7d", "dosage_form": "TABLET", "pharm_class": ["Oxidation-Reduction Activity [MoA]", "Oxidation-Reduction Agent [EPC]"], "product_ndc": "58657-454", "generic_name": "Urinary Antiseptic Antispasmodic", "labeler_name": "Method Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Me NaPhos MB Hyo 1", "active_ingredients": [{"name": "HYOSCYAMINE SULFATE ANHYDROUS", "strength": ".12 mg/1"}, {"name": "METHENAMINE", "strength": "81.6 mg/1"}, {"name": "METHYLENE BLUE ANHYDROUS", "strength": "10.8 mg/1"}, {"name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE", "strength": "40.8 mg/1"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20151201", "listing_expiration_date": "20261231"}